Manoj M Wagle, Kiran Noel Lobo, Rajath Kanchan R, Adithya Chandrashekar, VM Subrahmanyam
Manoj M Wagle, Kiran Noel Lobo, Rajath Kanchan R, Adithya Chandrashekar, VM Subrahmanyam*
Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India – 576104.
Volume - 14,
Issue - 6,
Year - 2021
Fungal infections caused by Candida are often associated with increasing rates of morbidity and mortality. It is a serious concern for patients with immunocompromised system. The resistance to Ketoconazole, a known antifungal agent is increasing at an alarming rate and a number of such cases have been reported in the recent years. In order to circumvent this problem, a study was carried out using ketoconazole-areca nut (Areca catechu L.) combination. When this combination was tested against Candida albicans, there was an increase in the antifungal activity of ketoconazole. The study can be explored further for the design of suitable topical formulations containing the above combination in the treatment of cutaneous candidiasis.
Cite this article:
Manoj M Wagle, Kiran Noel Lobo, Rajath Kanchan R, Adithya Chandrashekar, VM Subrahmanyam. A Combination approach using Areca nut and Ketoconazole for Treating Cutaneous Candidiasis. Research Journal of Pharmacy and Technology. 2021; 14(6):3074-6. doi: 10.52711/0974-360X.2021.00537
Manoj M Wagle, Kiran Noel Lobo, Rajath Kanchan R, Adithya Chandrashekar, VM Subrahmanyam. A Combination approach using Areca nut and Ketoconazole for Treating Cutaneous Candidiasis. Research Journal of Pharmacy and Technology. 2021; 14(6):3074-6. doi: 10.52711/0974-360X.2021.00537 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-27
1. Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. BioMed research international. 2013 Oct; 2013.
2. Jangir N, Bakshi S, Vyas N. Isolation and Detection of Aspergillus and Candida Species in Sputum of HIV Positive Patients and it Correlate with CD4.Research Journal of Pharmacy and Technology.2012; 5(6): 785-8.
3. Dave RD, Vyasa BM, Daniel PS, Anand IS, Patel CN. A Review on Posaconazole: A Newer Antifungal. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 694-699.
4. Chandrashekar A, Muralidharan A, Koteshwara A, Alex AT, Subrahmanyam VM. Isolation and Characterization of an actinomycete strain producing an antifungal metabolite effective against Candida albicans. Research Journal of Pharmacy and Technology. 2019; 12(10): 4601-6.
5. Oh J, Freeman AF, Park M, Sokolic R, Candotti F, Holland SM, Segre JA, Kong HH, NISC Comparative Sequencing Program. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome research. 2013 Dec 1; 23(12): 2103-14.
6. Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clinical Infectious Diseases. 2019 May 17; 68(11): 1791-7.
7. Hay R. Ketoconazole. British Medical Journal (Clinical research ed.). 1982 Aug 28; 285(6342): 584
8. White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrobial agents and chemotherapy. 2002 Jun 1; 46(6): 1704-13.
9. Prasad R, Rawal MK. Efflux pump proteins in antifungal resistance. Frontiers in pharmacology. 2014 Aug 29; 5:202.
10. Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, Belyhun Y, Biadglegne F, Hurissa Z, Moges F, Isogai E. Frequent detection of ‘azole’resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC infectious diseases. 2013 Dec 1; 13(1): 82.
11. Sadeghi E, Karamiyar M, Nasimfar A, Ebrahimi M. Determining the Susceptibility Pattern of Different Candida Species, Isolated from Hospitalized Immunocompromised Patients in Urmia Hospitals, to Antifungal Drugs. Journal of Research in Medical and Dental Science. 2018 May 1; 6(3): 129-34. doi:10.5455/jrmds.20186321
12. Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey. Jundishapur journal of microbiology. 2015 Sep; 8(9). doi: 10.5812/jjm.28057
13. Bhat SK, Ashwin D, Mythri S, Bhat S. Arecanut (Areca catechu L) decreases Alzheimer’s disease symptoms: Compilation of research works. J. Med. Plants. 2017; 5:04-9.
14. Shwetha HR, Kotrashetti VS, Reddy N, Chaitanya BN. Estimation of the Major Constituents of Areca nut in its different forms. Austin J. Nutri. Food Sci. 2019; 7:1-5.
15. Rashid M, Shamsi S, Zaman R, Ilahi A. Areca catechu: enfolding of historical and therapeutical traditional knowledge with modern update. Int J Pharmacognocy. 2015; 2(5):221-8.
16. EPA U. Method 180.1: Determination of Turbidity by Nephelometry. Rev. 2.0. Methods for Chemical Analysis of Water and Wastes. 1993.
17. Magaldi S, Mata-Essayag S, De Capriles CH, Perez C, Colella MT, Olaizola C, Ontiveros Y. Well diffusion for antifungal susceptibility testing. International journal of infectious diseases. 2004 Jan 1; 8(1):39-45.
18. Valgas C, Souza SM, Smânia EF, Smania Jr A. Screening methods to determine antibacterial activity of natural products. Brazilian journal of microbiology. 2007 Jun; 38(2):369-80.
19. Tangarife-Castano V, Correa-Royero J, Zapata-Londono B, Durán C, Stanshenko E, Mesa-Arango AC. Anti-Candida albicans activity, cytotoxicity and interaction with antifungal drugs of essential oils and extracts from aromatic and medicinal plants. Infectio. 2011 Sep; 15(3):160-7.
20. Cyriac MB, Pai V, Varghese I, Shantaram M, Jose M. Antimicrobial properties of Areca catechu (Areca nut) husk extracts against common oral pathogens. International Journal of Research in Ayurveda and Pharmacy (IJRAP). 2012; 3(1):81-4.
21. Anthikat RR, Michael A, Kinsalin VA, Ignacimuthu S. Antifungal activity of Areca catechu L. Int. J. Pharmaceu. Clin. Sci. 2014; 4(1):1-3.
22. De Miranda CM, Van Wyk CW, Van Der Biji P, Basson NJ. The effect of areca nut on salivary and selected oral microorganisms. International Dental Journal. 1996 Aug; 46(4):350.